is semaglutide dangerous for weight loss Common And Rare Side Effects Of Semaglutide vs. Traditional Weight Loss
Description
Patients should not discontinue statins in favour of GLP-1 therapy for cholesterol management without explicit guidance from their healthcare provider, as this could compromise cardiovascular risk reduction
Incidences of acute pancreatitis and pancreatic cancer were reported to be increased with use of GLP-1RAs in the US Food and Drug Administrations database studies
The frequency of constipation varies by medication and dose
Current evidence shows no increased pancreatic cancer risk with GLP-1 medications
Brand Drugs Are No Longer In Shortage The FDA allows compounding pharmacies to make copies of brand drugs only if the brand drug is hard to get
